Pancreatic fistula: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "__NOTOC__ {{Infobox_Disease | Name = {{PAGENAME}} | Image = | Caption = | DiseasesDB = | ICD10 = | ICD9 = |...")
Tag: Replaced
 
(4 intermediate revisions by the same user not shown)
Line 18: Line 18:


==[[Pancreatic fistula overview|Overview]]==
==[[Pancreatic fistula overview|Overview]]==
A [[pancreatic]] [[fistula]] is an abnormal connection between the epithelialized surfaces of the [[pancreatic duct]] and adjacent or distant structures, [[organs]] or [[cavities]].
Clinical criteria defined by the International Study Group for [[Pancreatic]] [[Fistula]] (ISGPF) is a measurable [[Drain (surgery)|drain]] output containing [[pancreas]]-derived [[enzyme]] [[amylase]] which is greater than three times the upper limit of the normal serum level measured on or after postoperative day three.
A revised grading for [[pancreatic]] [[fistula]] was proposed by ISGPF, according to which [[pancreatic]] [[fistula]] is graded either into a new category which involve an [[asymptomatic]] leakage from the [[pancreas]] called [[biochemical]] leak (BL), or Grade B including patients who undergo [[surgical procedures]] such as [[percutaneous]] or [[endoscopic]] drainage or [[angiographic]] procedures in order to promote the healing of [[fistula]] and Grade C including patients with [[organ failure]] requiring reoperations and [[mortality]] as a result of complication from [[pancreatic]] [[fistula]].


==[[Pancreatic fistula historical perspective|Historical Perspective]]==
==[[Pancreatic fistula historical perspective|Historical Perspective]]==
There is no historical significance associated with pancreatic fistula.


==[[Pancreatic fistula classification|Classification]]==
==[[Pancreatic fistula classification|Classification]]==
[[Pancreatic]] [[fistula]] can be classified anatomically as;
*[[Internal]] [[fistula]]: The [[pancreatic duct]] communicates with [[internal organs]] or [[body cavity]] such as [[Pleural cavity|pleural]] or [[peritoneal]] [[cavity]].
*External [[fistula]]: The [[pancreatic duct]] communicates with the [[skin]], otherwise known as pancreaticocutaneous [[fistula]].<ref name="pmid18053844">{{cite journal| author=Morgan KA, Adams DB| title=Management of internal and external pancreatic fistulas. | journal=Surg Clin North Am | year= 2007 | volume= 87 | issue= 6 | pages= 1503-13, x | pmid=18053844 | doi=10.1016/j.suc.2007.08.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18053844  }} </ref>
Pancreatic fistula can also be classified based on the [[anatomy]] of the [[pancreatic duct]] and the location of [[injury]] as;
*Type 1 [[pancreatic]] [[fistula]]: Involves [[injury]] to the [[pancreatic]] [[parenchyma]] with leakage from the [[distal]] part of the [[pancreatic duct]] or the side branches.
*Type 2 [[pancreatic]] [[fistula]]: Involves [[injury]] to and leak from the main [[pancreatic duct]].
*Type 3 [[pancreatic]] [[fistula]]: Occurs as a result of [[proximal]] or [[distal]] [[pancreatectomy]].<ref name="pmid28780610">{{cite journal| author=Mutignani M, Dokas S, Tringali A, Forti E, Pugliese F, Cintolo M | display-authors=etal| title=Pancreatic Leaks and Fistulae: An Endoscopy-Oriented Classification. | journal=Dig Dis Sci | year= 2017 | volume= 62 | issue= 10 | pages= 2648-2657 | pmid=28780610 | doi=10.1007/s10620-017-4697-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28780610  }} </ref>
[[Pancreatic]] [[fistula]] is classified into two categories on the basis of [[clinical]] manifestations, [[complications]] and severity by the ISGPF as;
*[[Biochemical]] [[pancreatic]] [[fistula]]: This category includes fistula with no significant [[clinical]] [[symptoms]].
*Clinically relevant [[pancreatic]] [[fistula]]: This category includes [[fistulas]] under grade B and C, which shows significant clinical [[symptoms]] and require surgical [[interventions]], re-surgeries and can complicate into [[organ failure]] and death.<ref name="pmid31840199">{{cite journal| author=Jiang L, Ning D, Chen X| title=Prevention and treatment of pancreatic fistula after pancreatic body and tail resection: current status and future directions. | journal=Front Med | year= 2020 | volume= 14 | issue= 3 | pages= 251-261 | pmid=31840199 | doi=10.1007/s11684-019-0727-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31840199  }} </ref>


==[[Pancreatic fistula pathophysiology|Pathophysiology]]==
==[[Pancreatic fistula pathophysiology|Pathophysiology]]==
The [[pathophysiology]] of [[pancreatic]] [[fistula]] involves the disruption of the [[pancreatic duct]] either from an [[iatrogenic]] insult, underlying [[inflammatory process]] or [[trauma]]. The disruption of the [[pancreatic duct]] causes gradual loss of the integrity of the tissue resulting in the leakage of the [[pancreatic]] [[fluid]] which induces [[inflammation]] and erosions, thereby leading to the formation of abnormal connections between the [[duct]] and the surrounding structures.<ref name="pmid29588609">{{cite journal| author=Nahm CB, Connor SJ, Samra JS, Mittal A| title=Postoperative pancreatic fistula: a review of traditional and emerging concepts. | journal=Clin Exp Gastroenterol | year= 2018 | volume= 11 | issue=  | pages= 105-118 | pmid=29588609 | doi=10.2147/CEG.S120217 | pmc=5858541 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29588609  }} </ref><ref name="pmid21672661">{{cite journal| author=Hackert T, Werner J, Büchler MW| title=Postoperative pancreatic fistula. | journal=Surgeon | year= 2011 | volume= 9 | issue= 4 | pages= 211-7 | pmid=21672661 | doi=10.1016/j.surge.2010.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21672661  }} </ref>


==[[Pancreatic fistula causes|Causes]]==
==[[Pancreatic fistula causes|Causes]]==
[[Pancreatic]] [[fistula]] can result from different types of insults such as;<ref name="pmid24650171">{{cite journal| author=Larsen M, Kozarek R| title=Management of pancreatic ductal leaks and fistulae. | journal=J Gastroenterol Hepatol | year= 2014 | volume= 29 | issue= 7 | pages= 1360-70 | pmid=24650171 | doi=10.1111/jgh.12574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24650171  }} </ref><ref name="pmid28040257">{{cite journal| author=Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M | display-authors=etal| title=The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. | journal=Surgery | year= 2017 | volume= 161 | issue= 3 | pages= 584-591 | pmid=28040257 | doi=10.1016/j.surg.2016.11.014 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28040257  }} </ref>
*[[Iatrogenic]]: External [[pancreatic]] [[fistula]] is most commonly [[iatrogenic]] in [[etiology]]. [[Trauma]] to the [[duct]] during [[surgery]] such as [[pancreaticoduodenectomy]], [[distal]] [[pancreatectomy]], during [[endoscopic]] intervention, [[extraction]] of a [[biopsy]] sample, [[pancreatic]] [[resection]] or as a complication of drainage of [[pancreatic pseudocyst]].
*Non-iatrogenic: Includes [[pathology]] of the [[gland]] such as [[acute]] or [[chronic pancreatitis]] or [[trauma]] to the [[abdominal]] structures or [[organs]] leading to [[fistula]] formation.


==[[Pancreatic fistula differential diagnosis|Differentiating Pancreatic fistula from other Diseases]]==
==[[Pancreatic fistula differential diagnosis|Differentiating Pancreatic fistula from other Diseases]]==
[[Differential diagnosis]] of a [[pancreatic]] [[fistula]] may include evaluation for:<ref name="pmid25893120">{{cite journal| author=Cochrane J, Schlepp G| title=Acute on chronic pancreatitis causing a highway to the colon with subsequent road closure: pancreatic colonic fistula presenting as a large bowel obstruction treated with pancreatic duct stenting. | journal=Case Rep Gastrointest Med | year= 2015 | volume= 2015 | issue=  | pages= 794282 | pmid=25893120 | doi=10.1155/2015/794282 | pmc=4381724 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25893120  }} </ref>
#[[Chronic liver disease]] leading to [[abdominal]] [[ascites]]
#[[Renal failure]]
#[[Heart failure]]
#[[Malignancy]]
#Conditions leading to [[pleural effusion]] such as [[malignancy]], [[trauma]] and [[infections]]
#[[Pancreatitis]]
#[[Retroperitoneal bleeding]]
#[[Bowel ischemia]]


==[[Pancreatic fistula epidemiology and demographics|Epidemiology and Demographics]]==
==[[Pancreatic fistula epidemiology and demographics|Epidemiology and Demographics]]==
[[Pancreatic]] [[fistula]] is a known complication following [[surgical resection]] of the [[pancreas]]. The [[incidence rate]] varies from as low as 5% in high volume centers to as high as 26%.<ref name="pmid24019766">{{cite journal| author=Reddymasu SC, Pakseresht K, Moloney B, Alsop B, Oropezia-Vail M, Olyaee M| title=Incidence of pancreatic fistula after distal pancreatectomy and efficacy of endoscopic therapy for its management: results from a tertiary care center. | journal=Case Rep Gastroenterol | year= 2013 | volume= 7 | issue= 2 | pages= 332-9 | pmid=24019766 | doi=10.1159/000354136 | pmc=3764947 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24019766  }} </ref> [[Acute]] [[fluid]] collection is recorded in up to 40% patients with [[acute pancreatitis]], out of which some cases develops true [[pancreatic]] [[fistula]] depending upon the severity of the insult.<ref name="pmid24650171">{{cite journal| author=Larsen M, Kozarek R| title=Management of pancreatic ductal leaks and fistulae. | journal=J Gastroenterol Hepatol | year= 2014 | volume= 29 | issue= 7 | pages= 1360-70 | pmid=24650171 | doi=10.1111/jgh.12574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24650171  }} </ref> Post-operative [[pancreatic]] [[Fistula|fistulae]] can affect 13% to 41% of patients after [[pancreatic]] [[resection]], making it a known source of [[morbidity]] and [[mortality]]. [[Pancreatic]] [[fistula]] can lead to certain severe [[complications]] if not addressed on time, as it carries a [[mortality]] risk of 25% in patients with grade C [[pancreatic]] [[fistula]]. The overall [[mortality rate]] is 1%. The [[incidence]] of [[pancreatic]] [[fistula]] varies depending on the type of [[pancreatic]] [[resection]] as it can be as low as 3% following a [[pancreatic]] head [[resection]] to as high as 30% after [[distal]] [[pancreatectomy]].<ref name="pmid29588609">{{cite journal| author=Nahm CB, Connor SJ, Samra JS, Mittal A| title=Postoperative pancreatic fistula: a review of traditional and emerging concepts. | journal=Clin Exp Gastroenterol | year= 2018 | volume= 11 | issue=  | pages= 105-118 | pmid=29588609 | doi=10.2147/CEG.S120217 | pmc=5858541 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29588609  }} </ref><ref name="pmid21672661">{{cite journal| author=Hackert T, Werner J, Büchler MW| title=Postoperative pancreatic fistula. | journal=Surgeon | year= 2011 | volume= 9 | issue= 4 | pages= 211-7 | pmid=21672661 | doi=10.1016/j.surge.2010.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21672661  }} </ref>


==[[Pancreatic fistula risk factors|Risk Factors]]==
==[[Pancreatic fistula risk factors|Risk Factors]]==
According to [[Fistula]] Risk Scoring (FRS) system, the risk factors for the development of [[pancreatic]] [[fistula]] depends upon:
*Texture of the [[gland]]: Soft texture of the [[gland]] is identified as a predictive risk factor.
*[[Pathology]]: [[Carcinoma]] of the [[duodenum]], [[ampulla]], [[cystic duct]] and [[islet cell]] carries high risk for [[fistula]] development compared to the [[glandular]] [[carcinoma]] such as [[pancreatic]] [[Ductal carcinoma|ductal]] [[adenocarcinoma]] or [[chronic pancreatitis]].
*[[Diameter]] of the [[pancreatic duct]]: Small [[pancreatic duct]] diameter <3mm is identified as a risk factor for the development of [[fistula]] formation, specifically a diameter of <1mm carries a high risk.
*Intraoperative blood loss: >1000ml is associated with a high risk of [[fistula]] formation.
*Other risk factors may include male gender, excessive fluid administration during surgery, [[Fasting plasma glucose|fasting]] [[blood]] [[glucose]] <108 mg/dl and an increase remnant [[gland]] volume. Some studies have reported both [[malnutrition]] and [[obesity]] as risk factors for the development of [[pancreatic cancer]].


==[[Pancreatic fistula natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[Pancreatic fistula natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
History and clinical presentation depends upon the size, location and connection of the [[pancreatic]] [[fistula]] with the involved [[Organ (anatomy)|organ]] or [[cavity]].
Clinical presentation may range from being [[asymptomatic]] to showing a variety of [[Signs and Symptoms|signs]] and [[symptoms]] resulting from fluid accumulation such as [[nausea]], [[vomiting]], [[hypotension]], [[infection]], [[tachycardia]], [[pain]], [[weight loss]], [[ileus]] and severe symptoms such as unrelenting [[pain]] and [[sepsis]].
External [[pancreatic]] [[fistula]] presents with [[pancreatic]] [[fluid]] accumulation noticeable on the [[skin]] surface.
[[Internal]] [[pancreatic]] [[fistula]] may present with [[ascites]] or [[pleural effusion]] as fluid accumulates within the [[abdominal]] or [[thoracic]] cavity.
Complications arising from a [[pancreatic]] [[fistula]] are due to the undrained [[pancreatic]] [[fluid]] accumulation and erosions caused by the enzymatically active substances of the fluid which affects the surrounding [[tissues]]. The most commonly observed complications are:
#[[Wound]] [[infection]] and [[sepsis]]
#[[Hemorrhage]]
#[[Internal]] and/or external [[fistula]]
#[[Pancreatic pseudocyst]]
#[[Delayed gastric emptying]]
#[[Walled off pancreatic necrosis]]
#Prolongation of the hospital stay
#[[Pancreatic]] [[ascites]]
#High [[amylase]] [[pleural effusion]]
#Disconnected [[duct]] [[syndrome]]
#Multisystem involvement eventually leading to [[multiorgan failure]] and/or death.
[[Pancreatic]] [[fistula]] that are less severe are reported to heal in a duration of 4-6 weeks with conservative management only. 80% of the external [[fistula]] and 50-65% of the [[internal]] [[fistula]] are reported to close eventually with conservative measures which involve stabilization of the patient with supportive therapies. However, [[pancreatic]] [[fistula]] can lead to significant [[morbidity]] if not addressed on time. Surgical intervention provides resolution of the [[fistula]] with a 90-92% success rate.


==Diagnosis==
==Diagnosis==


===History and clinical presentation:===
===History and clinical presentation:===
A [[pancreatic]] [[fistula]] with leakage of fluid can be diagnosed in some cases with typical history and clinical presentation, such as patient presenting with [[pancreatitis]] followed by recurrence, persistent symptoms or post [[pancreatic]] [[resection]] fluid drainage with increase amylase level. However, most cases are far more challenging which require [[imaging]] techniques and examination of the fluid samples withdrawn from the leak to help diagnose the [[fistula]].


===Imaging:===
===Imaging:===
The imaging techniques used to confirm the diagnosis of [[pancreatic]] [[fistula]] may include [[abdominal]] [[ultrasound]], [[Computed tomography|CT-scan]] of the [[abdomen]], pancreatogram, [[endoscopic retrograde cholangiopancreatography]] (ERCP), [[magnetic resonance cholangiopancreatography]] (MRCP) and [[fine needle aspiration]] of the fluid using [[endoscopic ultrasound]] (EUS). [[ERCP]] can be used for both diagnosis and therapeutic purposes such as placement of [[stent]] during the procedure to facilitate the closure of [[fistula]].


===Laboratory tests:===
===Laboratory tests:===
Fluid samples collected via [[thoracentesis]], [[paracentesis]] or fluid collected via [[percutaneous]] drainage from an external [[fistula]] can be analyzed for [[amylase]] level, which helps solidify the diagnosis of [[pancreatic cancer]]. [[Complete blood count]] is necessary to check for any ongoing [[infection]] or [[hemorrhage]]. Complete metabolic panel including [[inflammatory]] markers, [[Electrolyte|serum electrolytes]], [[liver function tests]], [[calcium]], [[albumin]], [[amylase]] and [[lipase]] should be sent to [[laboratory]] for evaluation. Furthermore, [[pancreatic]] [[fistula]] leak presenting as [[ascites]] or [[pleural effusion]] should be analyzed for fluid [[protein]], [[albumin]], [[lactate dehydrogenase]], [[glucose]], gram cultures and total cell count. [[Pancreatic]] fluid [[amylase]] level will be >1000 u/dl.


==Treatment==
==Treatment==
Treatment of a [[pancreatic]] [[fistula]] includes early recognition of the problem which is the key to careful management in order to prevent the consequent complications. Management of [[pancreatic]] [[fistula]] requires a multidisciplinary team which includes interventional [[radiologists]], [[endoscopy]] specialist and surgeons and include the following steps:
#[[Biochemical]] leak: Patients with [[biochemical]] leak are clinically [[asymptomatic]] with an [[amylase]] rich [[pancreatic]] fluid drain and can be managed conservatively. Patients should be kept under observation with close monitoring for signs of complications in order to avoid its progression to clinically relevant [[pancreatic]] [[fistula]]. The drain placed intraoperatively are usually kept to support the spontaneous closure of the [[fistula]]. Drainage output and inflammatory markers such as [[C-reactive protein]] and [[leucocyte]] count are regularly monitored to prevent fluid collections that may lead to life threatening sequalae.
#Grade B or C [[pancreatic]] [[fistula]]:
*Non-Surgical approach: Primary management involves treatment with non-surgical minimally invasive catheter drain placement. [[Imaging]] techniques such as [[Computed tomography|CT-scan]] in combination with interventional drain placement can help resolve peri-[[pancreatic]] fluid collection that went unrecognized and developed eventually. [[Antibiotic]] treatment is given to prevent [[abdominal]] [[infections]]. One life threatening condition that may complicate a grade B or C [[fistula]] is [[hemorrhage]] of a nearby [[vessel]] by the enzymatically active [[pancreatic]] fluid, which can be promptly evaluated with the help of [[CT angiography|CT]]-[[angiogram]] to identify the location of the bleeding vessel and can be managed via [[angiographic]] placement of a [[stent]] or [[embolization]].
*Surgical management: Conditions which requires urgent evacuation of large amount of blood that cannot be attained with minimally invasive techniques necessitates surgical interventions which include emergency [[laparotomy]], intra-abdominal lavage and drainage of infected fluid collections widely. Conditions which involves [[necrosis]], life threatening [[sepsis]] or complicated pancreatic fistula may require the [[resection]] of the remnant [[pancreas]].
Supportive care which is proven beneficial for both [[biochemical]] leaks and patients who develop [[sepsis]] and/or [[hemorrhage]] as a complication of [[pancreatic]] [[fistula]] include stabilizing the patient, [[pancreatic]] secretion control, nil per oral by ideally starting temporary [[parenteral nutrition]] and correction of the fluid and [[Electrolyte|electrolytes]] abnormalities. [[Somatostatin]] analogs such as [[octreotide]] are used commonly to control the [[pancreatic]] secretion, however no significant benefit is observed with its use in patients with already established [[pancreatic]] [[fistula]].
==Case Studies==


[[Pancreatic fistula case study one|Case #1]]


[[Category:Organ disorders]]
[[Category:Organ disorders]]

Latest revision as of 12:32, 10 April 2021

Pancreatic fistula
MeSH D010185

Pancreatic fistula Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancreatic fistula from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

ERCP

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancreatic fistula On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancreatic fistula

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancreatic fistula

CDC on Pancreatic fistula

Pancreatic fistula in the news

Blogs on Pancreatic fistula

Directions to Hospitals Treating Pancreatic fistula

Risk calculators and risk factors for Pancreatic fistula

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancreatic fistula from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and clinical presentation:

Imaging:

Laboratory tests:

Treatment

References